Towards HOMe-based Albuminuria Screening: an implementation study testing two approaches

Completed

• Conditions: Cardiovasular disease; kidney disease; 10011082; 10029149; 10003216

• Registration Number: NL-OMON50434
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15032

Inclusion Criteria

- Individuals aged 45-80 years
- Living in the region of Breda, the Netherlands

Exclusion Criteria

- Individuals younger than 45 years or older than 80 years
- Not living in the region of Breda, the Netherlands

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>* Participation rate of the two different screening techniques (PeeSpot vs. ACR<br /><br>| EU).<br /><br><br /><br>* Yield of albuminuria screening from both screening methods (PeeSpot vs. ACR |<br /><br>EU):<br /><br>- number of subjects with elevated albuminuria,<br /><br>- number of subjects with elevated albuminuria and with newly diagnosed<br /><br>risk factors including hypertension, diabetes, hypercholesterolemia, and<br /><br>impaired kidney function)</p><br>